Novartis updates label for psoriasis drug in EU
The Committee for Medicinal Products for Human Use (CHMP) has approved a label update for Novartis’s Cosentyx (secukinumab), the first interleukin-17A (IL-17A) approved to treat psoriasis...
Subscribe to Read More..
Your comment will be posted after it is approved.
Leave a Reply.
Create your own unique website with customizable templates.